PubMed Health⌕ Search

Biomedical subjects

J W van Kleef

Publications and source records attributed to J W van Kleef.

47 records · Page 3Linked to original sources

Pharmacokinetics of lignocaine and bupivacaine in surgical patients following epidural administration. Simultaneous investigation of absorption and disposition kinetics using stable isotopes.

The pharmacokinetics of lignocaine (lidocaine) and bupivacaine following epidural administration were studied in 12 surgical patients using a stable isotope method. Shortly after epidural administration of the agent to be evaluated, a deuterium-labelled analogue was administered intravenously. Plasma concentrations of the unlabelled and the deuterium-labelled local anaesthetics were determined using gas chromatography and mass fragmentography. The pharmacokinetic behaviour of both agents was consistent with a 2-compartment open model and two parallel first-order absorption processes. The mean distribution and elimination half-lives were 12 minutes and 100 minutes for lignocaine, and 22 minutes and 143 minutes for bupivacaine. The mean volumes of the central compartment and the mean steady-state volumes of distribution were: lignocaine, 43L and 99L; bupivacaine, 33L and 68L. Total plasma clearances averaged 0.95 L/min (57 L/h) for lignocaine and 0.52 L/min (31.2 L/h) for bupivacaine. The half-lives, characterising the fast and slow absorption processes, were 9.3 and 82 minutes for lignocaine, and 7.0 minutes and 362 minutes for bupivacaine; the fractions of the doses absorbed in the fast and slow processes were lignocaine 0.38 and 0.58, bupivacaine 0.28 and 0.66, respectively. The results indicate that the local anaesthetics are completely absorbed from the epidural space into the general circulation. The initial absorption rates of both local anaesthetics appear to be similar, but, later, the absorption of bupivacaine proceeds much more slowly than the absorption of lignocaine.

Absorption↗

Epidural anesthesia with bupivacaine: effects of age on neural blockade and pharmacokinetics.

Effects of aging after epidural administration of 0.5% bupivacaine without epinephrine were studied in two groups of patients, between 20 and 55 yr old and older than 55 yr, respectively. All patients received 95 mg bupivacaine HCl. The onset of analgesia in caudad segments decreased with age and the upper level of analgesia increased with age. Effects of age on duration of anesthesia could not be demonstrated. The total plasma clearance of bupivacaine decreased and the terminal half-life increased with age. Age had no effect on the peak plasma concentrations and time to peak concentrations.

Adult↗

Spinal anesthesia with glucose-free bupivacaine: effects of age on neural blockade and pharmacokinetics.

Effects of age on spinal anesthesia using glucose-free 0.5% bupivacaine without epinephrine were studied in two groups of patients, one between 20 and 55 yr old, the other older than 55 yr. All patients received 15 mg bupivacaine. The time to onset of analgesia in caudad segments and the time to maximal motor blockade decreased with age. The upper level of analgesia did not change significantly with increasing age. The times to recovery from analgesia at T12 and for the total disappearance of analgesia were longer in the older patient group. Effects of age on duration of motor blockade could not be demonstrated. Peak plasma concentrations of bupivacaine were significantly greater and the total plasma clearance significantly decreased in older patients. Age had no effect on time to peak concentration or the terminal half-life.

Adult↗

Spinal anesthesia with hyperbaric lidocaine and bupivacaine: effects of epinephrine on the plasma concentration profiles.

The effects of epinephrine on the plasma concentration profiles and some derived pharmacokinetic parameters were studied after subarachnoid injection of hyperbaric lidocaine and bupivacaine solutions. Addition of epinephrine to the local anesthetic solution reduced the mean peak plasma concentration of lidocaine from 526 to 376 ng/ml, but did not significantly reduce the mean peak plasma concentration of bupivacaine (70 vs 56 ng/ml). Epinephrine did not affect the times at which the peak concentrations were reached, the terminal half-lives, or the total plasma clearances. The observed effects of epinephrine on the peak plasma concentrations are consistent with the vascular activity of lidocaine and bupivacaine, respectively.

Adult↗

Epidural anesthesia with lidocaine and bupivacaine: effects of epinephrine on the plasma concentration profiles.

The effects of epinephrine on the plasma concentrations and derived pharmacokinetic parameters were studied after epidural administration of lidocaine and bupivacaine. Addition of epinephrine to the local anesthetic solutions reduced the mean peak plasma concentrations of lidocaine and bupivacaine from 2.2 to 1.7 micrograms/ml (23%) and from 0.73 to 0.53 microgram/ml (28%), respectively, but did not alter the times at which the peak concentrations were reached. Epinephrine also did not alter the terminal half-lives or the total plasma clearances. The results suggest that addition of epinephrine to minimize plasma concentrations is as relevant with bupivacaine as it is with lidocaine.

Adult↗

Plasma concentrations of lidocaine and bupivacaine after subarachnoid administration.

Plasma concentrations were measured after subarachnoid administration of 75 mg lidocaine in a hyperbaric solution and 15 mg bupivacaine in either a hyperbaric or an isobaric solution. Peak concentration times (tmax), peak concentrations (Cmax), apparent elimination half-lives (t1/2el), and areas under the curves (AUC) were determined. The values of tmax, Cmax, t1/2el and AUC were 66 +/- 32 min, 444 +/- 203 ng/ml, 2.0 +/- 0.3 h, and 87.0 +/- 9.8 mg . 1(-1) . min, respectively, for lidocaine. Those obtained after administration of a hyperbaric bupivacaine solution were 54 +/- 11 min, 63 +/- 22 ng/ml, 3.6 +/- 1.4 h, and 19.1 +/- 5.4 mg . 1(-1) . min. Results, obtained with isobaric bupivacaine solutions, were: 86 +/- 24 min, 63 +/- 15 ng/ml, 3.2 +/- 0.4 h, and 18.1 +/- 5.4 mg . 1(-1) . min. The results indicate roughly similar absorption rates from the subarachnoid space into the general circulation after administration of hyperbaric solutions of lidocaine and bupivacaine. Bupivacaine tended to be absorbed slower when it is administered in an isobaric solution.

Adolescent↗

Gas chromatographic determination of bupivacaine in plasma using a support coated open tubular column and a nitrogen-selective detector.

A capillary gas chromatographic method for the quantitative determination of bupivacaine in plasma is described. Bupivacaine and an added internal standard were extracted from plasma with n-pentane. The extracted products were introduced into the gas chromatograph via a solid injection system. The combination of a support coated open tubular column and a nitrogen-selective detector insure a good selectivity and a high sensitivity. The coëfficient of variation at concentrations exceeding 3 ng bupivacaine/ml plasma is less than 6%. The detection limit is about 1 ng/ml.

Bupivacaine↗

Effect of epidural administration of bupivacaine (Marcaine) on monosynaptic reflex-depression.

The L5 and S1-segments of the spinal cord and relatively resistant to blockade. The extent and depth of the block are usually tested by pinprick. H-reflex depression (Hoffmann 1922, Magladery and McDougal 1950) was used to quantify differences between the 0.5%-solution and the 0.75%-solution of bupivacaine used for epidural anaesthesia. The H-reflex is a monosynaptic reflex representing the excitability of the motorneuron pool of the L5-S1 region of the spinal cord. Our results show a difference between the two concentrations favouring the 0.75% solution. The H-reflex is also a component in the complexity of control and servocircuits that play a role in the well-functioning of the spinal cord. Consequently we used its full recovery to rule out lasting toxic or irritating effects on the spinal cord. Bupivacaine 0.75% is not available in Europe whereas in the USA there is already wide experience in using this concentration. A comparison between 0.75% and 0.5% solutions reveals two important advantages in favour of the 0.75% solution: A higher intensity of motorblock [4, 15]. A lower incidence of incomplete blockade of the most resistant segments (L5-S1) [7, 8].

Action Potentials↗

Pharmacokinetics of lidocaine and bupivacaine and stable isotope labelled analogues: a study in healthy volunteers.

The pharmacokinetics of lidocaine and bupivacaine and tri-deuteromethyl-labelled lidocaine and bupivacaine were investigated in healthy volunteers. The deuterium-labelled and the unlabelled form of the drug to be investigated were simultaneously infused in 10 min. Plasma concentrations were determined using a combination of capillary gas chromatography and mass fragmentography. Bi-exponential functions were fitted to the plasma concentration-time data. The mean distribution and elimination half-lives were 8.4 +/- 5.9 min and 96 +/- 26 min for lidocaine, 9.2 +/- 7.0 min and 98 +/- 27 min for deuterium-labelled lidocaine, 15.3 +/- 9.9 min and 111 +/- 32 min for bupivacaine, and 15.2 +/- 10.9 min and 109 +/- 31 min for deuterium-labelled bupivacaine, respectively. The mean volumes of the central compartment and mean steady state volumes of distribution were: lidocaine 37 +/- 151 and 97 +/- 201, deuterium-labelled lidocaine 39 +/- 161 and 98 +/- 181, bupivacaine 27 +/- 111 and 66 +/- 231 and deuterium-labelled bupivacaine 28 +/- 121, and 65 +/- 221, respectively. The respective mean plasma clearances were 0.88 +/- 0.181 min-1, 0.87 +/- 0.181 min-1, 0.61 +/- 0.151 min-1, and 0.62 +/- 0.171 min-1. The results of the study indicate that substitution of a deuterated methyl group does not alter the pharmacokinetics of lidocaine and bupivacaine in healthy subjects.

Adult↗

Endocrine-metabolic response to abdominal aortic surgery: a randomized trial of general anesthesia versus general plus epidural anesthesia.

The influence of epidural anesthesia on the endocrine-metabolic response following abdominal aortic reconstruction was studied in a prospective randomized trial. Cortisol and catecholamine responses and nitrogen balance were measured in two groups of five patients receiving general anesthesia only (group 1) or general anesthesia combined with epidural bupivacaine (group 2). The study lasted from preoperatively until the first postoperative day. At 2100 hours on the day of surgery serum cortisol concentrations were higher in group 1 than in group 2 (1.41 versus 0.82 mumol/L; p < 0.01). Likewise the total perioperative hypercortisolemia, expressed as the area under the curve, was significantly higher in group 1 (11.7 versus 5.7 mumol/L/hr, p < 0.01). Intraoperative urinary excretion of epinephrine and postoperative norepinephrine excretion were significantly higher in group 1 than in group 2. Urinary excretion of free cortisol and cumulative nitrogen balance were not different between the groups. Although the number of patients was limited and the sensory nerve block level was not measured perioperatively, this study suggests that epidural anesthesia attenuates the stress response to aortic surgery.

Aged↗